🍽️ enalapril maleate,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

  1. Hypertension (High Blood Pressure): Enalapril maleate is widely prescribed for the management of hypertension. It works by inhibiting the action of angiotensin-converting enzyme (ACE), which is involved in the production of angiotensin II, a substance that causes blood vessels to constrict. By blocking the effects of angiotensin II, enalapril maleate helps to relax blood vessels, thereby lowering blood pressure.

  2. Heart Failure: Enalapril maleate is also used in the treatment of heart failure, a condition in which the heart is unable to pump blood effectively to meet the body's needs. By reducing the workload on the heart and improving cardiac function, enalapril maleate can help alleviate symptoms of heart failure, such as shortness of breath, fatigue, and fluid retention.

  3. Post-Myocardial Infarction (Heart Attack) Therapy: Enalapril maleate may be prescribed as part of the treatment regimen following a myocardial infarction (heart attack) to improve survival and reduce the risk of heart failure-related hospitalizations.

  4. Diabetic Nephropathy: Enalapril maleate is sometimes used to treat diabetic nephropathy, a type of kidney disease that occurs in people with diabetes. It can help slow the progression of kidney damage and reduce the risk of complications associated with diabetic nephropathy.

  5. Left Ventricular Dysfunction: Enalapril maleate may be prescribed to individuals with asymptomatic left ventricular dysfunction to reduce the risk of developing symptomatic heart failure.

  6. Prevention of Cardiovascular Events: In certain cases, enalapril maleate may be used to prevent cardiovascular events such as stroke and myocardial infarction in high-risk individuals, particularly those with a history of cardiovascular disease or other risk factors.

  7. Disease Progression: Enalapril maleate has been shown to slow the progression of heart failure and reduce the risk of hospitalization and mortality in patients with heart failure.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of enalapril maleate,(prescription) On Probiotics

Rank Probiotic Impact
species Lacticaseibacillus paracasei Reduces

Bacteria Impacted by enalapril maleate,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Roseburia genus Decreases 👪 Source Study
Bacteroides genus Decreases 👪 Source Study
Lacrimispora genus Decreases 👪 Source Study
Mediterraneibacter genus Decreases 👪 Source Study
Lacticaseibacillus genus Decreases 👪 Source Study
Lacticaseibacillus paracasei species Decreases 📓 Source Study
Roseburia hominis species Decreases 📓 Source Study
Bacteroides fragilis species Decreases 📓 Source Study H02076 Bacteroides infection
Lacrimispora saccharolytica species Decreases 📓 Source Study
Mediterraneibacter gnavus species Decreases 📓 Source Study
Lacticaseibacillus paracasei subsp. paracasei subspecies Decreases 👶 Source Study
Lacticaseibacillus paracasei subsp. tolerans subspecies Decreases 👶 Source Study

Impact of enalapril maleate,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Acne 0.3 0.3
ADHD 0.5 0.5 0
Age-Related Macular Degeneration and Glaucoma 0.5 0.5
Allergic Rhinitis (Hay Fever) 0.3 0.3
Allergies 0.2 0.3 -0.5
Allergy to milk products 0.3 0.3 0
Alzheimer's disease 1.1 1.4 -0.27
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.5 0.5 0
Ankylosing spondylitis 0.3 0.3 0
Anorexia Nervosa 1.1 -1.1
Asthma 1.1 0.8 0.38
Atherosclerosis 0.5 0.8 -0.6
Atrial fibrillation 0.5 0.3 0.67
Autism 1.1 1.1 0
Autoimmune Disease 0.5 -0.5
benign prostatic hyperplasia 0.3 -0.3
Biofilm 0 0
Bipolar Disorder 0.3 0.5 -0.67
Brain Trauma 0.8 -0.8
Cancer (General) 0.6 -0.6
Carcinoma 0.3 0.3 0
Celiac Disease 0.5 0.3 0.67
Cerebral Palsy 0.3 0.8 -1.67
Chronic Fatigue Syndrome 0.3 0.3 0
Chronic Kidney Disease 0.3 0.5 -0.67
Chronic Lyme 0.8 -0.8
Chronic Obstructive Pulmonary Disease (COPD) 0.5 -0.5
Chronic Urticaria (Hives) 0.2 -0.2
Coagulation / Micro clot triggering bacteria 0.5 -0.5
Cognitive Function 0.8 0.8 0
Colorectal Cancer 1.4 0.8 0.75
Constipation 0.3 0.5 -0.67
Coronary artery disease 0 1.1 0
COVID-19 0.3 0.8 -1.67
Crohn's Disease 1.1 1.1 0
Cushing's Syndrome (hypercortisolism) 0.3 -0.3
cystic fibrosis 0.8 -0.8
deep vein thrombosis 0.8 0.8 0
Depression 1.7 1.8 -0.06
Eczema 0 0.2 0
Endometriosis 0.3 0.5 -0.67
Epilepsy 0.5 0.3 0.67
erectile dysfunction 0.3 0.3
Fibromyalgia 0.5 0.8 -0.6
Functional constipation / chronic idiopathic constipation 0.5 1.1 -1.2
gallstone disease (gsd) 0.2 0.5 -1.5
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.2 0.2
Generalized anxiety disorder 0.3 0.8 -1.67
Gout 0.3 0.3
Graves' disease 0.3 0.8 -1.67
Gulf War Syndrome 0.2 -0.2
Halitosis 0.3 0.3
Hashimoto's thyroiditis 1.1 0.3 2.67
Heart Failure 0.3 0.5 -0.67
Hidradenitis Suppurativa 0.3 0.3
High Histamine/low DAO 0.5 0.5
hyperglycemia 0.3 -0.3
hypertension (High Blood Pressure 0.3 1.4 -3.67
Hypothyroidism 0.3 0.3
Hypoxia 0.3 0.3
IgA nephropathy (IgAN) 0.3 0.6 -1
Inflammatory Bowel Disease 0.9 1.1 -0.22
Insomnia 0.3 0.8 -1.67
Intelligence 0.3 0.3
Intracranial aneurysms 0.3 0.3
Irritable Bowel Syndrome 1.1 0.8 0.38
ischemic stroke 0.3 0.8 -1.67
Liver Cirrhosis 1.4 0.8 0.75
Long COVID 0.3 0.8 -1.67
Low bone mineral density 0.5 -0.5
ME/CFS with IBS 0.3 -0.3
ME/CFS without IBS 0 0.3 0
Menopause 0.5 -0.5
Metabolic Syndrome 1.1 1.4 -0.27
Mood Disorders 1.7 1.5 0.13
Multiple Sclerosis 1.1 -1.1
Multiple system atrophy (MSA) 0.4 0.4
myasthenia gravis 0.5 -0.5
neuropathic pain 1.2 -1.2
Neuropathy (all types) 0.8 -0.8
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0.8 0.8 0
NonCeliac Gluten Sensitivity 0.3 0.3 0
Obesity 1.2 1.7 -0.42
obsessive-compulsive disorder 0.5 0.3 0.67
Osteoarthritis 0.3 0.3 0
Osteoporosis 0.8 0.3 1.67
pancreatic cancer 0.3 -0.3
Parkinson's Disease 1.1 1.3 -0.18
Polycystic ovary syndrome 1.1 0.8 0.38
Primary sclerosing cholangitis 0.3 0 0
Psoriasis 0.2 0.8 -3
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 0.8 1.1 -0.38
Rosacea 0.5 -0.5
Schizophrenia 0.3 0.8 -1.67
Sjögren syndrome 0.3 -0.3
Sleep Apnea 0.8 -0.8
Slow gastric motility / Gastroparesis 0.3 0.3
Small Intestinal Bacterial Overgrowth (SIBO) 0.3 0.3
Stress / posttraumatic stress disorder 0.8 0.8 0
Systemic Lupus Erythematosus 0.5 0.7 -0.4
Tic Disorder 0.5 -0.5
Tourette syndrome 0.3 -0.3
Type 1 Diabetes 0.5 0.8 -0.6
Type 2 Diabetes 1.1 1.1 0
Ulcerative colitis 0.5 1.4 -1.8
Unhealthy Ageing 0.5 0.5 0
Vitiligo 0.5 0.5

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2026 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]